Research and development Driving scientific innovation to deliver the next generation of transformational medicines and vaccines for patients
Read morePress releases
- FDA approves GSK’s Voltaren Arthritis Pain for over-the-counter use in the United States
- GSK delivers 2019 sales of £33.8 billion +10% AER, +8% CER (Pro-forma +4% CER*)
- CEPI and GSK announce collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus
Tweets from GSK
-
GSK @GSK
#DYK there are nearly 30 million Americans who suffer from #osteoarthritis? Go #BehindTheScience to see how we hope to help those suffering from this condition have greater control in managing their health and wellbeing: gsk.to/37Is7KR
about 1 day ago
-
GSK @GSK
Thanks to all our employees, around the world, who have raised £4 million for our partnership with @savechildrenuk. Together we’ve helped nearly 3 million children in 46 countries. Learn more: gsk.to/2LDdSkZ 👇#globalhealthhd
about 4 days ago -
GSK @GSK
We’re pleased to see the earlier science undertaken at the GSK Vaccines Institute for Global Health leading to a new vaccine for typhoid, delivered by Biological E. Learn more: gsk.to/3bOh0nc
about 4 days ago
